FREE SHIPPING ON ORDERS OVER $150

dr reddy semaglutide title Today we launch, Obeda®, India's first DCGI-approved generic injection for Type 2 Diabetes. This product reinforces our purpose of good health cant wait, to bring high quality and affordable treatment Dr Reddy's Agrees to Rebrand

$27.77

Quantity
- +
Description

Trulicity is a prescription medication used to treat type 2 diabetes. It is in the class of drugs called GLP-1 receptor agonists and works by stimulating the release of insulin and decreasing the production of sugar by the liver. The pre-filled pens come in a pack of 4 and contain a solution of dulaglutide, the active ingredient, in a concentration of 1.5 mg per 0.5 mL. These pens are used to inject Trulicity subcutaneously (under the skin) once a week and are intended for single-use only. They are convenient and easy to use, allowing patients to self-administer their medication at home

dr reddy semaglutide title Today we launch, Obeda, India's first DCGI-approved generic injection for Type 2 Diabetes. This product reinforces our purpose of good health cant wait, to bring high quality and affordable treatment Dr Reddy's Agrees to Rebrand

With consistent use, expect appetite control, improved mood and metabolic regularity by week 4 backed by science

dr reddy semaglutide title Today we launch, Obeda, India's first DCGI-approved generic injection for Type 2 Diabetes. This product reinforces our purpose of good health cant wait, to bring high quality and affordable treatment Dr Reddy's Agrees to Rebrand

Codeage GLP-1 Probiotic+ is manufactured in the USA with global ingredients in a cGMP-certified facility

dr reddy semaglutide title Today we launch, Obeda, India's first DCGI-approved generic injection for Type 2 Diabetes. This product reinforces our purpose of good health cant wait, to bring high quality and affordable treatment Dr Reddy's Agrees to Rebrand

Lose weight as you get in shape with the Skinny Shot

dr reddy semaglutide title Today we launch, Obeda, India's first DCGI-approved generic injection for Type 2 Diabetes. This product reinforces our purpose of good health cant wait, to bring high quality and affordable treatment Dr Reddy's Agrees to Rebrand

All available medical policies are listed below as the default display

dr reddy semaglutide title Today we launch, Obeda, India's first DCGI-approved generic injection for Type 2 Diabetes. This product reinforces our purpose of good health cant wait, to bring high quality and affordable treatment Dr Reddy's Agrees to Rebrand

You may also like

recommand products